Curis, Inc. To Present At The Biotechnology Industry Organization (BIO) CEO & Investor Conference 2006
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 8, 2006--Curis, Inc. (NASDAQ: CRIS), a therapeutic drug development company, today announced that the Company will be presenting at the BIO CEO & Investor Conference on Tuesday, February 14th, at the Waldorf-Astoria Hotel in New York City.